GLP-1 Maintenance: What Happens When You Lower Your Dose, Switch Medications, or Stop Entirely
About this episode
The episode discusses the effects of lowering GLP-1 medication doses and switching medications after weight loss, based on new clinical trial data.
2:26 PMClaude responded: Dr.Dr. Spencer Nadolsky and Karl break down two brand new randomized controlled trials, Surmount-Maintain and Attain-Maintain, that put hard numbers on what actually happens to patients when they try to lower their tirzepatide dose, switch to oral orforglipron, or come off GLP-1 medicines entirely after significant weight loss. The data confirms what they have been seeing clinically for years: obesity biology fights hard to pull weight back up, only about 17 percent of people can come off these medicines and maintain their results, and for most patients the conversation is not about stopping but about finding the most effective and affordable long-term dosing strategy.
More episodes of Docs Who Lift
- Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian
Explore listener stats, chart rankings, contacts and more on the Docs Who Lift podcast page.